Hotline: +86-18022463983    020-85206863

Global Oncology (Anti-cancer Drugs) Market Research Report 2021

Published Date: 2021-10-08   |   Pages: 115   |   Tables: 134   |  Pharma & Healthcare

The global Oncology (Anti-cancer Drugs) market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

This report focuses on Oncology (Anti-cancer Drugs) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oncology (Anti-cancer Drugs) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Oncology (Anti-cancer Drugs) Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Others

Segment by Application

Chemotherapy

Targeted Therapy

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Roche

Novartis

Celgene

Amgen

Johnson & Johnson

GlaxoSmithKline

Eli lilly & Co

Pfizer

Merck & Co.

Sanofi

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Oncology (Anti-cancer Drugs) Market Overview

1.1 Product Overview and Scope of Oncology (Anti-cancer Drugs)

1.2 Oncology (Anti-cancer Drugs) Segment by Type

1.2.1 Global Oncology (Anti-cancer Drugs) Sales Growth Rate Comparison by Type (2021-2027)

1.2.2 Blood Cancer

1.2.3 Breast Cancer

1.2.4 Gastrointestinal Cancer

1.2.5 Prostate Cancer

1.2.6 Others

1.3 Oncology (Anti-cancer Drugs) Segment by Application

1.3.1 Global Oncology (Anti-cancer Drugs) Sales Comparison by Application: (2021-2027)

1.3.2 Chemotherapy

1.3.3 Targeted Therapy

1.3.4 Immunotherapy (Biologic Therapy)

1.3.5 Hormonal Therapy

1.3.6 Others

1.4 Global Oncology (Anti-cancer Drugs) Market Size Estimates and Forecasts

1.4.1 Global Oncology (Anti-cancer Drugs) Revenue 2016-2027

1.4.2 Global Oncology (Anti-cancer Drugs) Sales 2016-2027

1.4.3 Oncology (Anti-cancer Drugs) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Oncology (Anti-cancer Drugs) Market Competition by Manufacturers

2.1 Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturers (2016-2021)

2.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Oncology (Anti-cancer Drugs) Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Oncology (Anti-cancer Drugs) Manufacturing Sites, Area Served, Product Type

2.5 Oncology (Anti-cancer Drugs) Market Competitive Situation and Trends

2.5.1 Oncology (Anti-cancer Drugs) Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Oncology (Anti-cancer Drugs) Players Market Share by Revenue

2.5.3 Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oncology (Anti-cancer Drugs) Retrospective Market Scenario by Region

3.1 Global Oncology (Anti-cancer Drugs) Retrospective Market Scenario in Sales by Region: 2016-2021

3.2 Global Oncology (Anti-cancer Drugs) Retrospective Market Scenario in Revenue by Region: 2016-2021

3.3 North America Oncology (Anti-cancer Drugs) Market Facts & Figures by Country

3.3.1 North America Oncology (Anti-cancer Drugs) Sales by Country

3.3.2 North America Oncology (Anti-cancer Drugs) Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Oncology (Anti-cancer Drugs) Market Facts & Figures by Country

3.4.1 Europe Oncology (Anti-cancer Drugs) Sales by Country

3.4.2 Europe Oncology (Anti-cancer Drugs) Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Oncology (Anti-cancer Drugs) Market Facts & Figures by Region

3.5.1 Asia Pacific Oncology (Anti-cancer Drugs) Sales by Region

3.5.2 Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Oncology (Anti-cancer Drugs) Market Facts & Figures by Country

3.6.1 Latin America Oncology (Anti-cancer Drugs) Sales by Country

3.6.2 Latin America Oncology (Anti-cancer Drugs) Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Oncology (Anti-cancer Drugs) Market Facts & Figures by Country

3.7.1 Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country

3.7.2 Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4 Global Oncology (Anti-cancer Drugs) Historic Market Analysis by Type

4.1 Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2016-2021)

4.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2016-2021)

4.3 Global Oncology (Anti-cancer Drugs) Price by Type (2016-2021)

5 Global Oncology (Anti-cancer Drugs) Historic Market Analysis by Application

5.1 Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2016-2021)

5.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2016-2021)

5.3 Global Oncology (Anti-cancer Drugs) Price by Application (2016-2021)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Corporation Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.1.4 Roche Oncology (Anti-cancer Drugs) Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Corporation Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.2.4 Novartis Oncology (Anti-cancer Drugs) Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 Celgene

6.3.1 Celgene Corporation Information

6.3.2 Celgene Description and Business Overview

6.3.3 Celgene Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.3.4 Celgene Oncology (Anti-cancer Drugs) Product Portfolio

6.3.5 Celgene Recent Developments/Updates

6.4 Amgen

6.4.1 Amgen Corporation Information

6.4.2 Amgen Description and Business Overview

6.4.3 Amgen Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Amgen Oncology (Anti-cancer Drugs) Product Portfolio

6.4.5 Amgen Recent Developments/Updates

6.5 Johnson & Johnson

6.5.1 Johnson & Johnson Corporation Information

6.5.2 Johnson & Johnson Description and Business Overview

6.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Product Portfolio

6.5.5 Johnson & Johnson Recent Developments/Updates

6.6 GlaxoSmithKline

6.6.1 GlaxoSmithKline Corporation Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Portfolio

6.6.5 GlaxoSmithKline Recent Developments/Updates

6.7 Eli lilly & Co

6.6.1 Eli lilly & Co Corporation Information

6.6.2 Eli lilly & Co Description and Business Overview

6.6.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Product Portfolio

6.7.5 Eli lilly & Co Recent Developments/Updates

6.8 Pfizer

6.8.1 Pfizer Corporation Information

6.8.2 Pfizer Description and Business Overview

6.8.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.8.4 Pfizer Oncology (Anti-cancer Drugs) Product Portfolio

6.8.5 Pfizer Recent Developments/Updates

6.9 Merck & Co.

6.9.1 Merck & Co. Corporation Information

6.9.2 Merck & Co. Description and Business Overview

6.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Product Portfolio

6.9.5 Merck & Co. Recent Developments/Updates

6.10 Sanofi

6.10.1 Sanofi Corporation Information

6.10.2 Sanofi Description and Business Overview

6.10.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2016-2021)

6.10.4 Sanofi Oncology (Anti-cancer Drugs) Product Portfolio

6.10.5 Sanofi Recent Developments/Updates

7 Oncology (Anti-cancer Drugs) Manufacturing Cost Analysis

7.1 Oncology (Anti-cancer Drugs) Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Oncology (Anti-cancer Drugs)

7.4 Oncology (Anti-cancer Drugs) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Oncology (Anti-cancer Drugs) Distributors List

8.3 Oncology (Anti-cancer Drugs) Customers

9 Oncology (Anti-cancer Drugs) Market Dynamics

9.1 Oncology (Anti-cancer Drugs) Industry Trends

9.2 Oncology (Anti-cancer Drugs) Growth Drivers

9.3 Oncology (Anti-cancer Drugs) Market Challenges

9.4 Oncology (Anti-cancer Drugs) Market Restraints

10 Global Market Forecast

10.1 Oncology (Anti-cancer Drugs) Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Oncology (Anti-cancer Drugs) by Type (2022-2027)

10.1.2 Global Forecasted Revenue of Oncology (Anti-cancer Drugs) by Type (2022-2027)

10.2 Oncology (Anti-cancer Drugs) Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Oncology (Anti-cancer Drugs) by Application (2022-2027)

10.2.2 Global Forecasted Revenue of Oncology (Anti-cancer Drugs) by Application (2022-2027)

10.3 Oncology (Anti-cancer Drugs) Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Oncology (Anti-cancer Drugs) by Region (2022-2027)

10.3.2 Global Forecasted Revenue of Oncology (Anti-cancer Drugs) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

Table 1. Global Oncology (Anti-cancer Drugs) Sales (K MT) Growth Rate Comparison by Type (2021-2027)

Table 2. Global Oncology (Anti-cancer Drugs) Sales (K MT) Comparison by Application (2021-2027)

Table 3. Global Oncology (Anti-cancer Drugs) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)

Table 4. Key Manufacturers Oncology (Anti-cancer Drugs) Covered in This Study

Table 5. Global Oncology (Anti-cancer Drugs) Sales (K MT) of Key Manufacturers (2016-2021)

Table 6. Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturers (2016-2021)

Table 7. Global Oncology (Anti-cancer Drugs) Revenue (US$ Million) by Manufacturers (2016-2021)

Table 8. Global Oncology (Anti-cancer Drugs) Revenue Share by Manufacturers (2016-2021)

Table 9. Global Market Oncology (Anti-cancer Drugs) Average Price (USD/MT) of Key Manufacturers (2016-2021)

Table 10. Manufacturers Oncology (Anti-cancer Drugs) Manufacturing Sites and Area Served

Table 11. Manufacturers Oncology (Anti-cancer Drugs) Product Type

Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Oncology (Anti-cancer Drugs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2020)

Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Global Oncology (Anti-cancer Drugs) Sales by Region (2016-2021) & (K MT)

Table 16. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2016-2021)

Table 17. Global Oncology (Anti-cancer Drugs) Revenue by Region (2016-2021) & (US$ Million)

Table 18. North America Oncology (Anti-cancer Drugs) Sales by Country (2016-2021) & (K MT)

Table 19. North America Oncology (Anti-cancer Drugs) Sales Market Share by Country (2016-2021)

Table 20. North America Oncology (Anti-cancer Drugs) Revenue by Country (2016-2021) & (US$ Million)

Table 21. North America Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2016-2021)

Table 22. Europe Oncology (Anti-cancer Drugs) Sales by Country (2016-2021) & (K MT)

Table 23. Europe Oncology (Anti-cancer Drugs) Sales Market Share by Country (2016-2021)

Table 24. Europe Oncology (Anti-cancer Drugs) Revenue by Country (2016-2021) & (US$ Million)

Table 25. Europe Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2016-2021)

Table 26. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Region (2016-2021) & (K MT)

Table 27. Asia Pacific Oncology (Anti-cancer Drugs) Sales Market Share by Region (2016-2021)

Table 28. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2016-2021) & (US$ Million)

Table 29. Asia Pacific Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2016-2021)

Table 30. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2016-2021) & (K MT)

Table 31. Latin America Oncology (Anti-cancer Drugs) Sales Market Share by Country (2016-2021)

Table 32. Latin America Oncology (Anti-cancer Drugs) Revenue by Country (2016-2021) & (US$ Million)

Table 33. Latin America Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2016-2021)

Table 34. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2016-2021) & (K MT)

Table 35. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share by Country (2016-2021)

Table 36. Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Country (2016-2021) & (US$ Million)

Table 37. Middle East and Africa Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2016-2021)

Table 38. Global Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2016-2021)

Table 39. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2016-2021)

Table 40. Global Oncology (Anti-cancer Drugs) Revenue (Million US$) by Type (2016-2021)

Table 41. Global Oncology (Anti-cancer Drugs) Revenue Share by Type (2016-2021)

Table 42. Global Oncology (Anti-cancer Drugs) Price (USD/MT) by Type (2016-2021)

Table 43. Global Oncology (Anti-cancer Drugs) Sales (K MT) by Application (2016-2021)

Table 44. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2016-2021)

Table 45. Global Oncology (Anti-cancer Drugs) Revenue (Million US$) by Application (2016-2021)

Table 46. Global Oncology (Anti-cancer Drugs) Revenue Share by Application (2016-2021)

Table 47. Global Oncology (Anti-cancer Drugs) Price (USD/MT) by Application (2016-2021)

Table 48. Roche Corporation Information

Table 49. Roche Description and Business Overview

Table 50. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 51. Roche Oncology (Anti-cancer Drugs) Product

Table 52. Roche Recent Developments/Updates

Table 53. Novartis Corporation Information

Table 54. Novartis Description and Business Overview

Table 55. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 56. Novartis Oncology (Anti-cancer Drugs) Product

Table 57. Novartis Recent Developments/Updates

Table 58. Celgene Corporation Information

Table 59. Celgene Description and Business Overview

Table 60. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 61. Celgene Oncology (Anti-cancer Drugs) Product

Table 62. Celgene Recent Developments/Updates

Table 63. Amgen Corporation Information

Table 64. Amgen Description and Business Overview

Table 65. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 66. Amgen Oncology (Anti-cancer Drugs) Product

Table 67. Amgen Recent Developments/Updates

Table 68. Johnson & Johnson Corporation Information

Table 69. Johnson & Johnson Description and Business Overview

Table 70. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 71. Johnson & Johnson Oncology (Anti-cancer Drugs) Product

Table 72. Johnson & Johnson Recent Developments/Updates

Table 73. GlaxoSmithKline Corporation Information

Table 74. GlaxoSmithKline Description and Business Overview

Table 75. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 76. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product

Table 77. GlaxoSmithKline Recent Developments/Updates

Table 78. Eli lilly & Co Corporation Information

Table 79. Eli lilly & Co Description and Business Overview

Table 80. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 81. Eli lilly & Co Oncology (Anti-cancer Drugs) Product

Table 82. Eli lilly & Co Recent Developments/Updates

Table 83. Pfizer Corporation Information

Table 84. Pfizer Description and Business Overview

Table 85. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 86. Pfizer Oncology (Anti-cancer Drugs) Product

Table 87. Pfizer Recent Developments/Updates

Table 88. Merck & Co. Corporation Information

Table 89. Merck & Co. Description and Business Overview

Table 90. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 91. Merck & Co. Oncology (Anti-cancer Drugs) Product

Table 92. Merck & Co. Recent Developments/Updates

Table 93. Sanofi Corporation Information

Table 94. Sanofi Description and Business Overview

Table 95. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)

Table 96. Sanofi Oncology (Anti-cancer Drugs) Product

Table 97. Sanofi Recent Developments/Updates

Table 98. Production Base and Market Concentration Rate of Raw Material

Table 99. Key Suppliers of Raw Materials

Table 100. Oncology (Anti-cancer Drugs) Distributors List

Table 101. Oncology (Anti-cancer Drugs) Customers List

Table 102. Oncology (Anti-cancer Drugs) Market Trends

Table 103. Oncology (Anti-cancer Drugs) Growth Drivers

Table 104. Oncology (Anti-cancer Drugs) Market Challenges

Table 105. Oncology (Anti-cancer Drugs) Market Restraints

Table 106. Global Oncology (Anti-cancer Drugs) Sales Forecast by Type (2022-2027) & (K MT)

Table 107. Global Oncology (Anti-cancer Drugs) Sales Market Share Forecast by Type (2022-2027)

Table 108. Global Oncology (Anti-cancer Drugs) Revenue Forecast by Type (2022-2027) & (US$ Million)

Table 109. Global Oncology (Anti-cancer Drugs) Revenue Market Share Forecast by Type (2022-2027)

Table 110. Global Oncology (Anti-cancer Drugs) Sales Forecast by Application (2022-2027) & (K MT)

Table 111. Global Oncology (Anti-cancer Drugs) Sales Market Share Forecast by Application (2022-2027)

Table 112. Global Oncology (Anti-cancer Drugs) Revenue Forecast by Application (2022-2027) & (US$ Million)

Table 113. Global Oncology (Anti-cancer Drugs) Revenue Market Share Forecast by Application (2022-2027)

Table 114. Global Oncology (Anti-cancer Drugs) Sales Forecast by Region (2022-2027) & (K MT)

Table 115. Global Oncology (Anti-cancer Drugs) Sales Market Share Forecast by Region (2022-2027)

Table 116. Global Oncology (Anti-cancer Drugs) Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 117. Global Oncology (Anti-cancer Drugs) Revenue Market Share Forecast by Region (2022-2027)

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Oncology (Anti-cancer Drugs)

Figure 2. Global Oncology (Anti-cancer Drugs) Market Share by Type in 2020 & 2027

Figure 3. Blood Cancer Product Picture

Figure 4. Breast Cancer Product Picture

Figure 5. Gastrointestinal Cancer Product Picture

Figure 6. Prostate Cancer Product Picture

Figure 7. Others Product Picture

Figure 8. Global Oncology (Anti-cancer Drugs) Market Share by Application in 2020 & 2027

Figure 9. Chemotherapy

Figure 10. Targeted Therapy

Figure 11. Immunotherapy (Biologic Therapy)

Figure 12. Hormonal Therapy

Figure 13. Others

Figure 14. Global Oncology (Anti-cancer Drugs) Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 15. Global Oncology (Anti-cancer Drugs) Market Size 2016-2027 (US$ Million)

Figure 16. Global Oncology (Anti-cancer Drugs) Sales 2016-2027 (K MT)

Figure 17. Global Oncology (Anti-cancer Drugs) Market Size Market Share by Region: 2016 VS 20210 VS 2027

Figure 18. Oncology (Anti-cancer Drugs) Sales Share by Manufacturers in 2020

Figure 19. Global Oncology (Anti-cancer Drugs) Revenue Share by Manufacturers in 2020

Figure 20. The Global 5 and 10 Largest Oncology (Anti-cancer Drugs) Players: Market Share by Revenue in 2020

Figure 21. Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021

Figure 22. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2016-2021)

Figure 23. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region in 2020

Figure 24. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2016-2021)

Figure 25. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region in 2020

Figure 26. U.S. Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 27. Canada Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 28. Germany Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 29. France Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 30. U.K. Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 31. Italy Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 32. Russia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 33. China Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 34. Japan Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 35. South Korea Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 36. India Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 37. Australia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 38. Taiwan Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 39. Indonesia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 40. Thailand Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 41. Malaysia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 42. Philippines Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 43. Vietnam Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 44. Mexico Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 45. Brazil Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 46. Argentina Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 47. Turkey Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 48. Saudi Arabia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 49. U.A.E Oncology (Anti-cancer Drugs) Revenue Growth Rate (2016-2021) (US$ Million)

Figure 50. Sales Market Share of Oncology (Anti-cancer Drugs) by Type (2016-2021)

Figure 51. Sales Market Share of Oncology (Anti-cancer Drugs) by Application (2016-2021)

Figure 52. Sales Market Share of Oncology (Anti-cancer Drugs) by Application in 2020

Figure 53. Revenue Share of Oncology (Anti-cancer Drugs) by Application (2016-2021)

Figure 54. Revenue Share of Oncology (Anti-cancer Drugs) by Application in 2020

Figure 55. Manufacturing Cost Structure of Oncology (Anti-cancer Drugs)

Figure 56. Manufacturing Process Analysis of Oncology (Anti-cancer Drugs)

Figure 57. Oncology (Anti-cancer Drugs) Industrial Chain Analysis

Figure 58. Channels of Distribution

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

Our Clients